135 studies found for:    novel influenza a (h1n1)
Show Display Options
Rank Status Study
21 Unknown  Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
Conditions: Virus Diseases;   Respiratory Tract Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg;   Other: blood fix
22 Unknown  Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients
Conditions: Serology Analysis;   Novel H1N1 Influenza Vaccination;   Pediatric Haemato-oncology Patients
Intervention: Biological: Influenza A (H1N1) 2009 monovalent vaccine, inactivated
23 Completed Virus Shedding and Environmental Deposition of a Novel Influenza Virus
Condition: Novel (H1N1) Influenza
Intervention:
24 Enrolling by invitation Analysis of the Results From Influenza Rapid Test A Positive and H1N1 Real Time RT-PCR
Condition: H1N1 Influenza Virus
Intervention:
25 Completed
Has Results
Safety Study to Evaluate FluMist in Immunocompromised Children
Condition: Cancer
Interventions: Biological: FluMist;   Biological: Placebo
26 Completed Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects
Condition: Swine-Origin Influenza A H1N1 Virus
Intervention: Biological: Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
27 Completed Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients
Conditions: Lymphoma;   Multiple Myeloma;   Myeloproliferative Disease
Intervention: Biological: Reassortant vaccine virus NYMC X-179A (New York Medical College, New York) derived form the A/california/7/2009 (H1N1) virus
28 Unknown  Immunogenicity Study of S-OIV H1N1 Influenza Vaccine
Condition: Human Influenza
Intervention: Biological: split-virion, H1N1 vaccine of 15 μg
29 Completed
Has Results
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
Conditions: HIV Infections;   H1N1 Influenza Virus
Intervention: Biological: Influenza A (H1N1) monovalent vaccine
30 Completed Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects
Condition: Influenza
Intervention: Biological: Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
31 Unknown  Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
Condition: Influenza
Intervention: Biological: Inactivated H1N1 vaccine
32 Withdrawn Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1
Condition: Influenza
Interventions: Biological: Vaccine Sanofi A(H1N1) 15 ug & trivalent;   Biological: Vaccine Sanofi (H1N1) 15 ug.nonadyuvante;   Biological: Vaccine Sanofi A(H1N1) 7.5 ug
33 Completed
Has Results
Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth
Conditions: HIV Infections;   H1N1 Influenza Virus
Intervention: Biological: Influenza A (H1N1) 2009 monovalent vaccine
34 Terminated Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children
Condition: 2009 H1N1 Influenza
Interventions: Biological: Live Attenuated H1N1 Influenza Vaccine;   Biological: Influenza A (H1N1) 2009 Monovalent Vaccine;   Biological: Influenza A (H1N1) 2009 Monovalent Vaccine/ Influenza A (H1N1) Monovalent Vaccine Live
35 Completed H-IVIG Treatment for Severe H1N1 2009
Condition: Novel 2009 Influenza A (H1N1) Infection
Interventions: Drug: Hyperimmune intravenous immunoglobulin;   Drug: Intravenous immunoglobulin
36 Completed VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old
Conditions: Influenza A Virus, H1N1 Subtype;   Novel Swine-Origin
Intervention: Biological: VRC-FLUDNA057-00-VP
37 Completed
Has Results
A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age
Condition: Influenza
Interventions: Biological: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal];   Biological: Placebo
38 Completed Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
Conditions: HIV Infection;   Rheumatic Disease;   Cancer;   Transplant;   Pediatrics
Intervention: Biological: Adjuvanted influenza A(H1N1) vaccines
39 Completed Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors
Conditions: H1N1 Influenza Virus;   Invasive Solid Tumors
Interventions: Biological: adjuvanted A(H1N1) influenza vaccine;   Biological: non-adjuvanted A(H1N1) influenza vaccine
40 Completed Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva
Conditions: Healthy;   Immunosuppressed;   Asthmatic;   Neuromuscular Diseases
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years